Mitochondrial Dysfunction Therapeutics
Mitochondrial Dysfunction Therapeutics is a pharmacological intervention strategy that specifically targets and ameliorates impaired mitochondrial function in neurodegenerative diseases by restoring bioenergetic homeostasis, reducing oxidative stress, and preventing mitochondrial-mediated apoptotic signaling.
744
Publications
41.8K
Citations
5K
Authors
1.4K
Institutions
Publications per year
2017–2026
445
744
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong Yao, Hao Li, Peng Liao et al. · Signal Transduction and Targeted Therapy · 2024 · 989 citations · Full text
Selective targeting of an antioxidant to mitochondria
Robin A.J. Smith, Carolyn M. Porteous, Carolyn V. Coulter et al. · European Journal of Biochemistry · 1999 · 460 citations
1–5 of 744
5K
12
h-index
9
h-index
8
h-index
7
h-index
6
h-index
1–5 of 5K
1.4K

Chiang Mai University
Chiang Mai, Thailand
15 h-index
107 publications
7.2K citations

Nanjing Medical University
Nanjing, China
14 h-index
61 publications
3.1K citations
Inserm
Paris, France
13 h-index
61 publications
3.7K citations

Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
13 h-index
55 publications
2.2K citations

Cornell University
Ithaca, United States
12 h-index
32 publications
3.2K citations
Harvard University
Cambridge, United States
11 h-index
47 publications
9.2K citations

Shanghai Jiao Tong University
Shanghai, China
11 h-index
70 publications
2.7K citations

Sun Yat-sen University
Guangzhou, China
11 h-index
57 publications
2.7K citations
1–8 of 1.4K
18 publications · 784 citations
16
h-index
14 publications · 882 citations
14
h-index
Repository · 11 publications · 625 citations
11
h-index
11 publications · 474 citations
11
h-index
10 publications · 857 citations
10
h-index
1–5